every citation, with a link

Citation index

The references below are numbered to match the inline [N] markers used across the site. Channel labels (R / G / B) indicate which GLOW component the citation primarily addresses; M denotes a methodological or biochemical source not tied to a single component. Where a peer-reviewed DOI is available it is included; otherwise the PubMed or PMC identifier is given. All linked sources are publisher pages or PubMed Central full-text records.

Readers interested in the broader thymosin beta-4 program (parent of TB-500) or the full BPC-157 development history (including the unpublished PL-14736 Phase II) should follow the linked papers' own reference lists for the deeper trail.

Citation notes by channel

Channel R / GHK-Cu references ^{[1][2][3][4][5][17]} cover the 1994 Mulder diabetic-ulcer trial (the most-cited controlled human result for GHK-Cu), the Pickart 2014 transcriptomic Connectivity Map paper, two mouse lung-injury and fibrosis studies, the hair-follicle ex vivo work, and a 2025 liposomal-formulation review.

Channel G / BPC-157 references ^{[6][7][8][9][10][16][18]} cover the tendon-fibroblast growth-hormone-receptor work, the Achilles tendon transection model, the Src-Caveolin-1-eNOS vasomotor pathway, the 2025 McGuire narrative review of human evidence, two Sikiric mechanistic syntheses, and the Pliva PL-14736 paper that anchors the unpublished Phase II trial.

Channel B / TB-500 references ^{[11][12][13][14][15]} cover the biochemical basis for thymosin beta-4 as the major intracellular G-actin sequestering peptide, the 2023 Phase III ophthalmic trial of RGN-259 in neurotrophic keratopathy, the 2004 Nature cardiac-regeneration paper, the 2010 rat embolic-stroke model, and the 2011 myoblast-chemoattractant study. The 2024 engineered tandem-Tβ4 work is also referenced where the corneal repair section discusses recent formulation progress.